daunorubicin has been researched along with Soft Tissue Neoplasms in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (50.00) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chuman, H; Furuta, K; Hiramoto, N; Hosoi, H; Kobayashi, Y; Maruyama, D; Nomoto, J; Takeda, K; Tobinai, K; Tochigi, N; Watanabe, T; Yagyu, S | 1 |
| Corona, G; Crivellari, D; Lestuzzi, C; Lombardi, D; Lucenti, A; Magri, MD; Massacesi, C; Sorio, R; Talamini, R; Toffoli, G; Veronesi, A | 1 |
| de Planque, MM; Lankelma, J; Leyva, A; McVie, JG; Penders, PG; Pinedo, HM; Ten Bokkel-Huinink, WW | 1 |
| Miller, DR; Mitta, SK; Steinherz, L; Tan, CT | 1 |
| Das Gupta, TK; Stastny, JJ | 1 |
| Jelić, S; Kovcin, V; Kreacić, M; Radosavljević, D; Tomasević, Z; Vlajić, M | 1 |
| Krishan, A; KuKuruga, MA; Kunikane, H; Lucas, D; Ramachandran, C; Ryan, JR; Zalupski, MM | 1 |
| Gujral, S; Kochupillai, V; Kumar, L; Mohanti, BK; Wadhwa, J | 1 |
| Davis, M; Kelley, MR; Thomson, B; Tritt, R | 1 |
| Benjamin, RS | 1 |
| Davis, HL; Davis, TE | 1 |
| Brandi, M; De Lena, M; Logroscino, A; Lorusso, V; Maiello, E; Paradiso, A | 1 |
| Bozzi, D; Brandi, M; Calabrese, P; De Lena, M; Romito, S | 1 |
| Kolarić, K; Mechl, Z; Potrebica, V; Sopkova, B | 1 |
2 review(s) available for daunorubicin and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Adriamycin and other anthracycline antibiotics under study in the United States.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Daunorubicin; Doxorubicin; Drug Combinations; Hodgkin Disease; Humans; Leukemia; Neoplasm Metastasis; Neoplasms; Soft Tissue Neoplasms; United States | 1978 |
Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations.
Topics: Breast Neoplasms; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia; Lymphoma; Neoplasms; Sarcoma; Soft Tissue Neoplasms | 1979 |
1 trial(s) available for daunorubicin and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Chromatography, High Pressure Liquid; Daunorubicin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Idarubicin; Liver Neoplasms; Lung Neoplasms; Soft Tissue Neoplasms | 2006 |
11 other study(ies) available for daunorubicin and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Ewing sarcoma arising after treatment of diffuse large B-cell lymphoma.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Cyclophosphamide; Daunorubicin; Drug Therapy, Combination; Fatal Outcome; Female; Humans; In Situ Hybridization, Fluorescence; Lymphoma, Large B-Cell, Diffuse; Neoplasms, Second Primary; Prednisolone; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2013 |
Plasma concentrations of carminomycin and carminomycinol in man, measured by high pressure liquid chromatography.
Topics: Breast Neoplasms; Carubicin; Chromatography, High Pressure Liquid; Daunorubicin; Humans; Sarcoma; Soft Tissue Neoplasms; Time Factors | 1982 |
Phase I trial of rubidazone (NSC 164011) in children with cancer.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Daunorubicin; Drug Evaluation; Female; Humans; Infant; Leukemia; Leukocyte Count; Lymphoma; Male; Neuroblastoma; Platelet Count; Remission, Spontaneous; Soft Tissue Neoplasms | 1981 |
The use of daunomycin-antibody immunoconjugates in managing soft tissue sarcomas: nude mouse xenograft model.
Topics: Animals; Antibodies, Monoclonal; Daunorubicin; Doxorubicin; Humans; Immunotoxins; Male; Mice; Mice, Nude; Neoplasm Transplantation; Sarcoma, Experimental; Soft Tissue Neoplasms; Tissue Distribution; Transplantation, Heterologous | 1993 |
[A pilot study of high-dose zorubicin in advanced stages of soft tissue sarcoma in adults].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neutropenia; Pilot Projects; Prospective Studies; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Ventricular Function, Left | 1996 |
Flow cytometric analysis of P-glycoprotein expression and drug efflux in human soft tissue and bone sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antibodies; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Child; Daunorubicin; Drug Resistance, Neoplasm; Female; Flow Cytometry; Histiocytoma, Benign Fibrous; Humans; Leiomyosarcoma; Leukocyte Common Antigens; Liposarcoma; Male; Middle Aged; Osteosarcoma; Predictive Value of Tests; Prognosis; Sarcoma; Soft Tissue Neoplasms | 1997 |
Extramedullary myeloid cell tumour: presentation as anterior chest wall mass during AML relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Soft Tissue Neoplasms; Thoracic Neoplasms | 1999 |
Histology-specific expression of a DNA repair protein in pediatric rhabdomyosarcomas.
Topics: Adolescent; Biotransformation; Carbon-Oxygen Lyases; Cell Nucleus; Child; Child, Preschool; Daunorubicin; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; DNA-Binding Proteins; DNA, Neoplasm; Drug Resistance, Neoplasm; Feedback; Female; Forkhead Box Protein O1; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Infant; Male; Models, Biological; Neoplasm Metastasis; Neoplasm Proteins; Oxidation-Reduction; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Single-Blind Method; Soft Tissue Neoplasms; Transcription Factors | 2001 |
Intravenous administration of cyclophosphamide, methotrexate and 5-fluorouracil in metastatic breast cancer. A pilot study.
Topics: Administration, Oral; Bone Neoplasms; Breast Neoplasms; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Remission Induction; Soft Tissue Neoplasms | 1988 |
4-Demethoxydaunorubicin administered orally in advanced breast cancer. A phase II study.
Topics: Acute Kidney Injury; Administration, Oral; Adult; Aged; Bone Marrow Diseases; Bone Neoplasms; Breast Neoplasms; Daunorubicin; Female; Humans; Idarubicin; Middle Aged; Nausea; Soft Tissue Neoplasms; Stomach Ulcer; Vomiting | 1988 |
Phase II study of oral 4-demethoxydaunorubicin in previously treated (except anthracyclines) metastatic breast cancer patients.
Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Idarubicin; Lymphatic Metastasis; Middle Aged; Remission Induction; Soft Tissue Neoplasms | 1987 |